FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
1-Year Return 24.36%
This Quarter Return
+57.23%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
AUM
$278M
AUM Growth
+$60.4M
Cap. Flow
-$34.2M
Cap. Flow %
-12.31%
Top 10 Hldgs %
88.48%
Holding
20
New
2
Increased
3
Reduced
6
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INSM icon
1
Insmed
INSM
$30.8B
$44.6M 16.02%
1,533,883
-443,353
-22% -$12.9M
CBAY
2
DELISTED
Cymabay Therapeutics
CBAY
$34.9M 12.56%
2,631,258
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$28.9M 10.38%
245,424
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26.7M 9.59%
518,560
-337,340
-39% -$17.4M
OPTN
5
DELISTED
OptiNose
OPTN
$25M 8.99%
161,827
+47,924
+42% +$7.4M
IMMU
6
DELISTED
Immunomedics Inc
IMMU
$22.3M 8.02%
1,161,965
-43,398
-4% -$834K
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$20M 7.19%
384,993
-101,631
-21% -$5.28M
REPL icon
8
Replimune Group
REPL
$447M
$18.7M 6.73%
1,229,656
CYTK icon
9
Cytokinetics
CYTK
$6.12B
$13.9M 5.01%
1,723,170
+1,548,022
+884% +$12.5M
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$6.39B
$11.1M 3.99%
405,026
+5,026
+1% +$138K
ALEC icon
11
Alector
ALEC
$278M
$10.7M 3.84%
+1,203,462
New +$10.7M
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$10.1M 3.62%
211,823
-50,000
-19% -$2.38M
SIBN icon
13
SI-BONE Inc
SIBN
$677M
$3.87M 1.39%
205,621
VYGR icon
14
Voyager Therapeutics
VYGR
$232M
$3.4M 1.22%
+177,804
New +$3.4M
ABUS icon
15
Arbutus Biopharma
ABUS
$855M
$2.88M 1.04%
804,446
-777,829
-49% -$2.78M
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$2.75B
$1.15M 0.41%
63,922
ACRS icon
17
Aclaris Therapeutics
ACRS
$211M
-748,132
Closed -$5.53M
ORTX
18
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-66,836
Closed -$10.5M
EIDX
19
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-431,781
Closed -$5.94M
PTLA
20
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-250,000
Closed -$4.88M